wandrews@cooley.com
Wade W. Andrews is a business associate focusing on general corporate law.
Download full bio
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion
Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion
Reneo Pharmaceuticals – $94 Million IPO
Equillium – $65.4 Million IPO
HTG Completes its Initial Public Offering
View all
University of California Hastings College of LawJD, magna cum laude, 2009
Brigham Young University BS, 2005
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion December 12, 2022
Turning Point Therapeutics to Sell to Bristol Myers Squibb for $4.1 Billion June 3, 2022
Tocagen – $98 Million IPO April 20, 2017
+1 858 550 6042
Locations